Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

US Patent 10172853 · Granted Jan 8, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Rapamycin for the treatment of lymphangioleiomyomatosis2024
Rapamycin for the treatment of lymphangioleiomyomatosis2023
Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for trea2023
Inhalable rapamycin formulation for treating age-related conditions2023
Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for trea2022
Inhalable rapamycin formulation for the treatment of pulmonary hypertension2022
Intranasal delivery of dihydroergotamine by precision olfactory device2021
Rapamycin for the treatment of lymphangioleiomyomatosis2021
Inhalable rapamycin formulation for treating age-related conditions2021
Polycyclic compounds and uses thereof2020
Ergoline compounds and uses thereof2020
Ergoline compounds and uses thereof2019